VRS
HZNP

Virginia Retirement Systems’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Virginia Retirement Systems’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,100
Closed -$625K – 1269
2022
Q3 		$625K Buy
+10,100
New +$706K 0.01% 740
2022
Q1 		$3.11M Sell
29,600
-16,200
-35% -$1.58M 0.03% 351
2021
Q4 		$4.93M Buy
+45,800
New +$5M 0.03% 306
2021
Q2 		– Sell
-60,100
Closed -$5.53M – 1184
2021
Q1 		$5.53M Sell
60,100
-77,600
-56% -$6.55M 0.05% 301
2020
Q4 		$10.1M Buy
137,700
+110,000
+397% +$8.18M 0.11% 216
2020
Q3 		$2.15M Sell
27,700
-22,800
-45% -$1.57M 0.02% 362
2020
Q2 		$2.81M Sell
50,500
-1,300
-3% -$55.6K 0.03% 336
2020
Q1 		$1.53M Sell
51,800
-4,100
-7% -$139K 0.02% 433
2019
Q4 		$2.02M Buy
55,900
+1,000
+2% +$30.7K 0.02% 440
2019
Q3 		$1.5M Sell
54,900
-10,400
-16% -$269K 0.02% 524
2019
Q2 		$1.57M Buy
65,300
+1,000
+2% +$25.4K 0.02% 503
2019
Q1 		$1.7M Buy
+64,300
New +$1.52M 0.02% 484
2017
Q2 		– Sell
-24,400
Closed -$361K – 1191
2017
Q1 		$361K Buy
24,400
+6,000
+33% +$97.2K ﹤0.01% 956
2016
Q4 		$298K Sell
18,400
-200
-1% -$3.63K ﹤0.01% 873
2016
Q3 		$337K Buy
+18,600
New +$363K ﹤0.01% 803
2015
Q4 		$349K Buy
16,100
+400
+3% +$7.79K 0.01% 808
2015
Q3 		$311K Buy
+15,700
New +$496K ﹤0.01% 819
2015
Q2 		– Sell
-13,300
Closed -$345K – 1060
2015
Q1 		$345K Buy
+13,300
New +$244K 0.01% 805

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Virginia Retirement Systems's HZNP Position: Q4 2022 in Review

Virginia Retirement Systems sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 10,100 shares — an estimated $625K sold.

Virginia Retirement Systems first reported a position in HZNP in Q1 2015 and held it in 18 quarters. The position peaked at $10.1M in Q4 2020. 613 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

  • Virginia Retirement Systems reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 10,100 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $625K.
  • Virginia Retirement Systems first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 18 quarters.
  • Virginia Retirement Systems's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.1M in Q4 2020.
  • 613 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Virginia Retirement Systems's 13F filing for Q4 2022, filed 17 May 2023.